Michael Gelband’s Pulmonx LUNG Stock Holding History

Michael Gelband’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Sell	1,223,555 -720,279	-37%	-$992K	0.01%	913
2026 Q1	$2.51M	Sell	1,943,834 -7,339	-0.4%	-$12.1K	0.02%	691
2025 Q4	$4.31M	Buy	+1,951,173	New	+$3.67M	0.03%	532
2025 Q2	–	Sell	-41,958	Closed	-$282K	–	1764
2025 Q1	$282K	Sell	41,958 -6,089	-13%	-$43.1K	﹤0.01%	1243
2024 Q4	$326K	Sell	48,047 -27,199	-36%	-$179K	﹤0.01%	1256
2024 Q3	$624K	Buy	75,246 +26,694	+55%	+$193K	﹤0.01%	1118
2024 Q2	$308K	Buy	+48,552	New	+$373K	﹤0.01%	1324
2024 Q1	–	Sell	-33,362	Closed	-$425K	–	1765
2023 Q4	$425K	Buy	33,362 +12,267	+58%	+$128K	﹤0.01%	1078
2023 Q3	$218K	Buy	21,095 +10,406	+97%	+$121K	﹤0.01%	1498
2023 Q2	$140K	Buy	+10,689	New	+$131K	﹤0.01%	1727
2023 Q1	–	Sell	-22,275	Closed	-$188K	–	1973
2022 Q4	$188K	Buy	+22,275	New	+$212K	﹤0.01%	1465
2021 Q2	–	Sell	-4,945	Closed	-$226K	–	2612
2021 Q1	$226K	Sell	4,945 -22,898	-82%	-$1.31M	﹤0.01%	1824
2020 Q4	$1.92M	Buy	+27,843	New	+$1.36M	0.02%	555

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Michael Gelband's LUNG Position: Q2 2026 in Review

Michael Gelband reduced its Pulmonx (LUNG) stake by 37% in Q2 2026, selling an estimated $992K and leaving 1,223,555 shares worth $1.59M. The position accounts for 0.01% of the portfolio, ranked #913.

Michael Gelband first reported a position in LUNG in Q4 2020 and has held it in 13 quarters since. The position peaked at $4.31M in Q4 2025. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

Michael Gelband held 1,223,555 shares of Pulmonx worth $1.59M as of Q2 2026.
Michael Gelband sold 720,279 Pulmonx shares in Q2 2026, an estimated $992K.
Pulmonx made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #913 holding.
Michael Gelband first reported a position in Pulmonx in Q4 2020 and has held it in 13 quarters since.
Michael Gelband's Pulmonx position peaked at $4.31M in Q4 2025.
108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.